WMCWeill Medical College of Cornell University · Biomedical Engineering
Bladder Innovation Lab
Benedict Shek Hang Law · New York, New York
Research Focus
Dr. Benedict Shek Hang Law's lab at Weill Medical College focuses on developing innovative therapies for bladder cancer, particularly for patients who can't undergo standard invasive treatments. His research aims to improve drug delivery methods to ensure higher effectiveness and lower recurrence of cancer, using novel peptide-based systems that minimize the invasive techniques currently used.
bladder cancerdrug deliveryintravesical chemotherapypeptide therapyimmune checkpoint inhibitorsbladder infectionsnon-muscle invasive BCmuscle invasive BC
Research Aims
5AIM 01Investigate the physicochemical properties of a new peptide analogue for enhanced drug delivery
AIM 02Evaluate the therapeutic efficacy of a drug-peptide conjugate for bladder cancer treatment
AIM 03Assess the combination of a drug-peptide conjugate with immune checkpoint inhibitors
AIM 04Understand the anti-tumor activities through immune profiling
AIM 05Explore the potential of the new delivery system for treating other diseases.
Skills the Lab Values
cell cultureanimal modelsdrug conjugationchemotherapy delivery systemsimmune profilingpharmacodynamicsmolecular characterizationtissue collectionanalytical chemistrysurface modification